Peripheral Thrombotic Lesions
Conditions
Interventions
Case series:None
Sponsors
Tianjin Medical University General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The patient signed the informed consent form, voluntarily participated in this study, and was willing and capable of cooperating with the data collection in this study. 2. The researchers selected the subjects based on the product indications and contraindications, and treated the subjects using the product in accordance with the product instructions: (1) The disposable peripheral vascular thrombus aspiration catheter was used in conjunction with a compatible thrombus aspiration control system for treating thrombus in the following areas: upper and lower extremity peripheral arteries with a diameter of >= 3.0 mm; upper extremity peripheral veins with a diameter of >= 3.0 mm; iliac-femoral and lower extremity veins with a diameter of >= 3.0 mm; arteriovenous fistula vessels with a diameter of >= 3.0 mm. When used together with the thrombus aspiration control system's thrombolysis spray function, it can inject the liquid specified by the physician (including thrombolytic drugs) into the peripheral vascular system. It is used for peripheral vascular arteriovenous thrombus stenosis or occlusive lesions, or for thrombus lesions in percutaneous transluminal angioplasty (PTA) or stent procedures that require pre-treatment for thrombus reduction. (2) The peripheral venous thrombus aspiration catheter was used together with the company's thrombus aspiration control instrument to remove thrombus from the following areas: upper extremity peripheral veins with a diameter of >= 6.0 mm; iliac-femoral and lower extremity veins with a diameter of >= 6.0 mm; when used together with the thrombus aspiration control instrument's thrombolysis spray function, the liquid specified by the physician (including thrombolytic agents) was infused into the peripheral venous vascular system.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindications to endovascular interventional therapy. 2. Patients with uncorrected bleeding disorders who cannot receive thrombolytic agents. 3. Patients who cannot tolerate the use of contrast agents. 4. Patients with target vascular lesions that cannot be traversed with a guidewire.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Technical Success Rate of the Thrombectony; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cincal Success Rale of the Thrombectony;Perioperative Primary Patency Rate; | — |
Countries
China
Contacts
Public ContactDai Xiangchen
Tianjin Medical University General Hospital
Outcome results
None listed